MenoP-Care Capsules
Natural health product licensed in Canada
- Licence holder
- Viva Pharmaceutical Inc.
- NPN or DIN-HM
- 80061623
- Status
- Inactive licence
- Licence date
- 8 June 2015
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine D: up to 20 µg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 5 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Conditions légales
Actaea racemosa L.: Seuls les extraits aqueux et hydro-alcooliques de titre faible (30 %) sont admis. La portion journalière recommandée ne doit pas conduire à une ingestion de glycosides de triterpène (calculés comme 27-déoxyactéine) supérieure à 3 mg.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Vitex agnus-castus L.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Glycyrrhiza glabra L.: La portion journalière recommandée ne doit pas conduire à une ingestion d'acide glycyrrhizinique supérieure à 100 mg. L'étiquetage doit comporter un avertissement avec la teneur suivante: "Ne pas utiliser pendant plus de 6 semaines sans avis médical." L'étiquetage doit comporter un avertissement déconseillant l'emploi chez les enfants.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Dioscorea villosa L.: Les matières premières végétales doivent avoir subi les étapes traditionnelles d'épluchage, de lavage et de traitement thermique. L'absence d'alcaloïdes et de composés cyanogènes doit être démontrée par des bulletins d'analyse.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Humulus lupulus Source : Plante entière Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 100 mg | 25 mg | Not calculated |
| Extrait d'isoflavone de soja Source : Glycine max - Graine Potency : 0.18 mg Genistein | 150 mg | Not calculated |
| Extrait d'isoflavone de soja Source : Glycine max - Graine Potency : 40 mg Isoflavones | Not specified | Not calculated |
| Extrait d'isoflavone de soja Source : Glycine max - Graine Potency : 16.3 mg Genistin | Not specified | Not calculated |
| Calcium Source : Produit de chélation de calcium et de protéine végétale hydrolysée (PVH) | 100 mg | 200,000 µg |
| Vitamine D Source : Cholécalciférol | 10 mcg | 20 µg |
| Vitamine D Source : Cholécalciférol | 400 UI | 20 µg |
| Actaea racemosa Source : Racine et rhizome Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 160 mg Potency : 2.5 % Triterpene glycosides | 40 mg | Not calculated |
| Vitex agnus-castus Source : Fruit Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 320 mg | 80 mg | Not calculated |
| Glycyrrhiza glabra Source : Racine et stolon Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 750 mg | 75 mg | Not calculated |
| Dioscorea villosa Source : Racine Extract : Matériel brut sec Extraction ratio : 5:1 Dry plant equivalent : 375 mg | 75 mg | Not calculated |
Non-medicinal ingredients
Cellulose microcristalline, Dioxyde de silicium, Stéarate de magnésium, Carbonate de calcium, Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 2 days |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to attenuate/reduce bone mineral density (BMD) loss in post-menopausal women when used in conjunction with adequate amounts of calcium and vitamin D. May reduce severe and frequent menopausal symptoms (such as hot flashes and/or night sweats). Calcium intake, when combined with sufficient vitamin D, a healthy diet, and regular exercise, may reduce the risk of developing osteoporosis. Helps in the development and maintenance of bones and teeth. Helps in the absorption and use of calcium and phosphorus. (Traditionally) used in Herbal Medicine to help relieve the pain associated with menstruation. (Traditionally) used in Herbal Medicine to help relieve muscle and joint pain associated with rheumatic conditions (such as rheumatoid arthritis, osteoarthritis and/or fibrositis), and of pain associated with neuralgia (such as sciatica). (Traditionally) used in Herbal Medicine to help ease nervous tension (calmative). Used in Herbal Medicine as a hormone normaliser to help stabilise menstrual cycle irregularities. Used in Herbal Medicine to help relieve symptoms associated with menopause, such as hot flushes. Traditionally used in Herbal Medicine as an expectorant to help relieve chest complaints, such as catarrhs, coughs and bronchitis. Used in Herbal Medicine to help relieve inflammatory conditions of the gastrointestinal tract, such as gastritis in adults.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80061623
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.